Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 20-11-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,7538 USD -3,85% Intraday-grafiek van Perspective Therapeutics, Inc. -20,07% -72,59%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-3,85%-20,07%-67,23%-77,16%-72,59%-63,93%-70,81%-84,62%-86,66% 91,03 mln.
-2,49%-3,76%-4,65%-16,14%+55,34%+50,31%+62,10%+8,06% - 63,66 mld.
-0,63%-2,91%+8,42%-5,45%+18,97%+6,55%+89,34%+235,88%+6.283,23% 58,56 mld.
-2,37%-2,22%+4,43%+9,96%+21,09%+21,77%+84,58%-14,09%+258,39% 54,19 mld.
-2,19%-6,15%+1,16%+4,40%+28,68%+12,43%+111,40%+7,24%+1.140,69% 44,66 mld.
-1,89%-7,28%-11,14%-5,39%+9,05%+9,30%+18,50%-8,33%+207,20% 40,51 mld.
-0,93%-0,47%+7,79%+10,76%+23,56%+19,34%+41,83%+16,18%+194,57% 36,27 mld.
+1,11%-6,44%-17,03%-23,04%+102,39%+127,46%+675,37%+441,85% - 34,89 mld.
-0,80%+0,61%+32,40%+61,27%+71,14%+76,27%+61,80%+26,88%+178,63% 32,26 mld.
-2,17%+16,65%+50,29%+12,37%-18,79%-28,89%+479,93%+363,99%+866,69% 31,01 mld.
-6,57%-12,37%-17,09%-19,69%+30,28%+34,03%-15,63%-62,97% - 21,45 mld.
-0,52%-5,42%-11,32%-30,55%-14,96%-15,30%-16,67%-72,06% - 20,07 mld.
-3,70%-6,64%-7,84%-1,64%+8,70%+3,16%+120,99%+168,95%+1.598,78% 17,08 mld.
-1,26%-8,23%+5,79%-0,22% - - - - - 16,58 mld.
-1,82%-6,33%+0,08%+19,51%+47,46%+52,03%+204,57%+258,46%+276,41% 15,77 mld.
-0,42%-3,05%+5,44%+17,11%+36,70%+47,63%+64,99%-22,61%+100,66% 16 mld.
-4,15%-7,00%-8,86%+6,48%+57,57%+87,50%+63,50%-17,26%+333,90% 15,06 mld.
-8,71%-20,29%-6,38%-21,43%+159,62%+161,01%+279,30%+684,99%+614,56% 13,83 mld.
-1,92%-4,08%+0,79%+8,41%+2,46%+13,46%-31,12%-34,76%+144,35% 13,99 mld.
-5,59%-11,07%-15,81%-25,95%+1,58%-6,61%+333,75% - - 12,15 mld.
Gemiddelde -2,54%-5,35%-2,54%-3,82%+29,91%+31,97%+134,62%+105,32%+865,10% 28 mld.
Gewogen gemiddelde per kap. -2,03%-3,52%+2,47%+0,41%+34,20%+33,46%+139,51%+102,44%+1.360,93%
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.